Optimizing the Transition to Biosimilars: Considerations for Payers - Episode 2
Ryan Haumschild, PharmD, MS, MBA, continues focusing on transition optimization, explaining how to efficiently create your inventory, how his use of biosimilars will change in the future, and offering advice to those looking to transition to biosimilars.
"continued" - Google News
October 27, 2021 at 01:47AM
https://ift.tt/3mgXEhN
Optimizing Transitions to Biosimilars Continued - AJMC.com Managed Markets Network
"continued" - Google News
https://ift.tt/2WiTaZN
https://ift.tt/2YquBwx
Bagikan Berita Ini
0 Response to "Optimizing Transitions to Biosimilars Continued - AJMC.com Managed Markets Network"
Post a Comment